Analyst Ratings For Acasti Pharma Inc (NASDAQ:ACST)
Today, HC Wainwright initiated coverage on Acasti Pharma Inc (NASDAQ:ACST) with a Buy with a price target of $6.00.
There are 1 Buy Ratings, no Strong Buy Ratings, no Sell Ratings, no Hold Ratings on the stock.
The current consensus rating on Acasti Pharma Inc (NASDAQ:ACST) is Buy with a consensus target price of $6.00 per share, a potential 391.80% upside.
Some recent analyst ratings include
- 6/26/2019-Acasti Pharma Inc (NASDAQ:ACST) has coverage initiated with a Buy ➝ Buy rating and $6.00 price target
- 1/29/2018-Acasti Pharma Inc (NASDAQ:ACST) had its Buy rating reiterated by Dawson James
- 1/5/2018-Acasti Pharma Inc (NASDAQ:ACST) has coverage initiated with a Buy rating and $7.00 price target
Recent Trading Activity for Acasti Pharma Inc (NASDAQ:ACST)
Shares of Acasti Pharma Inc closed the previous trading session at 1.24 up +0.19 17.94% with 1.15 shares trading hands.
